Massive Jury Award of $8 Billion that Hit Johnson & Johnson Highlights Risks of 'All-or-Nothing' Strategy

Outsized penalties awarded by some juries highlight risks in a longstanding strategy by drugmakers such as J&J of taking their chances at trial rather then settle product liability lawsuits brought by patients.

from Top World News- News18.com https://ift.tt/2AUKv5s